Bettina S Husebø1, Clive Ballard2, Dag Aarsland3, Geir Selbaek4, Dagrun D Slettebo5, Christine Gulla5, Irene Aasmul5, Torstein Habiger5, Tony Elvegaard5, Ingelin Testad6, Elisabeth Flo7. 1. Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway; Municipality of Bergen, Bergen, Norway. Electronic address: Bettina.Husebo@uib.no. 2. University of Exeter Medical School, Exeter, United Kingdom; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway. 3. Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway; Kings College, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom. 4. National Advisory Unit of Ageing and Health, Vestfold Hospital Trust, Tonsberg, Norway; Centre for Old Age Psychiatry Research, Innlandet Hospital Trust, Ottestad, Norway. 5. Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway. 6. Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway; University of Exeter Medical School, Exeter, United Kingdom. 7. Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway; Faculty of Psychology, University of Bergen, Norway.
Abstract
OBJECTIVES: To investigate if the multicomponent intervention of the COSMOS trial, combining communication, systematic pain management, medication review, and activities, improved quality of life (QoL) in nursing home patients with complex needs. DESIGN: Multicenter, cluster-randomized, single-blinded, controlled trial. SETTING:Thirty-three nursing homes with 67 units (clusters) from 8 Norwegian municipalities. PARTICIPANTS: Seven hundred twenty-three patients with and without dementia (≥65 years) were cluster randomized to usual care or intervention in which health care staff received standardized education and on-site training for 4 months with follow-up at month 9. MEASUREMENTS: Primary outcome was change in QoL as measured by QUALIDEM (QoL dementia scale); QUALID (QoL late-stage dementia scale), and EQ-VAS (European QoL-visual analog scale) from baseline to month 4. Secondary outcomes were activities of daily living (ADL), total medication, staff distress, and clinical global impressions of change (CGIC). RESULTS: During the active intervention, all 3 QoL measures worsened, 2 significantly (QUALID P = .04; QUALIDEM P = .002). However, follow-up analysis from month 4 to 9 showed an intervention effect for EQ-VAS (P = .003) and QUALIDEM total score (P = .01; care relationship P = .02; positive affect P = .04, social relations P = .01). The secondary outcomes of ADL function, reduction of medication (including psychotropics) and staff distress, improved significantly from baseline to month 4. Intervention effects were also demonstrated for CGIC at month 4 (P = .023) and 9 (P = .009), mainly because of deterioration in the control group. CONCLUSION AND IMPLICATIONS: Temporarily, the QoL decreased in the intervention group, leading to our hypothesis that health care staff may be overwhelmed by the work-intensive COSMOS intervention period. However, the decrease reversed significantly during follow-up, indicating a potential learning effect. Further, the intervention group improved in ADL function and received less medication, and staff reported less distress and judged COSMOS as able to bring about clinically relevant change. This suggests that nonpharmacologic multicomponent interventions require long follow-up to ensure uptake and beneficial effects.
RCT Entities:
OBJECTIVES: To investigate if the multicomponent intervention of the COSMOS trial, combining communication, systematic pain management, medication review, and activities, improved quality of life (QoL) in nursing home patients with complex needs. DESIGN: Multicenter, cluster-randomized, single-blinded, controlled trial. SETTING: Thirty-three nursing homes with 67 units (clusters) from 8 Norwegian municipalities. PARTICIPANTS: Seven hundred twenty-three patients with and without dementia (≥65 years) were cluster randomized to usual care or intervention in which health care staff received standardized education and on-site training for 4 months with follow-up at month 9. MEASUREMENTS: Primary outcome was change in QoL as measured by QUALIDEM (QoL dementia scale); QUALID (QoL late-stage dementia scale), and EQ-VAS (European QoL-visual analog scale) from baseline to month 4. Secondary outcomes were activities of daily living (ADL), total medication, staff distress, and clinical global impressions of change (CGIC). RESULTS: During the active intervention, all 3 QoL measures worsened, 2 significantly (QUALID P = .04; QUALIDEM P = .002). However, follow-up analysis from month 4 to 9 showed an intervention effect for EQ-VAS (P = .003) and QUALIDEM total score (P = .01; care relationship P = .02; positive affect P = .04, social relations P = .01). The secondary outcomes of ADL function, reduction of medication (including psychotropics) and staff distress, improved significantly from baseline to month 4. Intervention effects were also demonstrated for CGIC at month 4 (P = .023) and 9 (P = .009), mainly because of deterioration in the control group. CONCLUSION AND IMPLICATIONS: Temporarily, the QoL decreased in the intervention group, leading to our hypothesis that health care staff may be overwhelmed by the work-intensive COSMOS intervention period. However, the decrease reversed significantly during follow-up, indicating a potential learning effect. Further, the intervention group improved in ADL function and received less medication, and staff reported less distress and judged COSMOS as able to bring about clinically relevant change. This suggests that nonpharmacologic multicomponent interventions require long follow-up to ensure uptake and beneficial effects.
Authors: Sebastian Voigt-Radloff; Claudia Bollig; Gabriel Torbahn; Michael Denkinger; Jürgen Bauer Journal: Z Gerontol Geriatr Date: 2020-02 Impact factor: 1.281
Authors: Stephanie L Harrison; Suzanne M Dyer; Kate E Laver; Rachel K Milte; Richard Fleming; Maria Crotty Journal: Cochrane Database Syst Rev Date: 2022-03-07
Authors: Frances Bunn; Claire Goodman; Kirsten Corazzini; Rachel Sharpe; Melanie Handley; Jennifer Lynch; Julienne Meyer; Tom Dening; Adam L Gordon Journal: Int J Environ Res Public Health Date: 2020-02-05 Impact factor: 3.390
Authors: Stefan Junge; Paul Gellert; Julie Lorraine O'Sullivan; Sebastian Möller; Jan-Niklas Voigt-Antons; Adelheid Kuhlmey; Johanna Nordheim Journal: Qual Life Res Date: 2020-01-18 Impact factor: 4.147
Authors: Bianca E M de Jong-Schmit; Rosalinde K E Poortvliet; Stefan Böhringer; Jonathan M K Bogaerts; Wilco P Achterberg; Bettina S Husebo Journal: Int J Geriatr Psychiatry Date: 2020-10-08 Impact factor: 3.485